AML1-ETO (RUNX1::RUNX1T1) FISH Test for AML-M2 in UAE | 700 AED | 2026 DHA Guidelines

تحليل اندماج AML1-ETO (RUNX1::RUNX1T1) بواسطة التهجين الموضعي المتألق (FISH) لسرطان الدم النقوي الحاد M2 في الإمارات | 700 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

ملخص تنفيذي: فحص معتمد بدقة 99.9%، جمع منزلي بمعايير سلسلة التبريد ISO، دعم تأميني مباشر، وإرشاد طبي عبر الهاتف.

Test Overview: AML1-ETO Fusion in AML-M2

The AML1-ETO FISH test detects the RUNX1::RUNX1T1 translocation characteristic of AML-M2, offering a definitive diagnosis and risk stratification with 99.9% analytical sensitivity. This test, performed on bone marrow or peripheral blood, delivers results in 3–4 days, enabling timely treatment decisions.

يكشف اختبار AML1-ETO عن اندماج الجينات المميز لسرطان الدم النقوي الحاد نمط M2، محققاً حساسية تشخيصية بنسبة 99.9%. يتم على نخاع العظم أو الدم المحيطي ويقدم النتائج خلال 3-4 أيام.

Feature	Our AML1-ETO FISH (بتقنيتنا)	Conventional Karyotyping (البديل)
Precision	>99% target specificity with locus-specific probes	Chromosome-level resolution, may miss cryptic translocations
Methodology	Fluorescence In-Situ Hybridization (FISH) – ISO-15189	Chromosome banding analysis
Turnaround	3–4 working days	7–10 days
Sample	Bone Marrow / Peripheral Blood	Bone Marrow only (requires metaphase cells)

Consultant Oncologist’s Note & Safety Protocol

Dr. PRABHAKAR REDDY (DHA License: 61713011), Consultant Haematologist-Oncologist, states: “A positive AML1-ETO result typically indicates a favorable prognosis in AML-M2 when integrated with clinical and morphological data. However, no single test dictates treatment – a thorough multidisciplinary evaluation is essential. I urge all patients to discuss these results with their treating oncologist before making any therapeutic changes.”

⚠️ Medication Safety Notice: Do not discontinue any prescribed chemotherapy, anticoagulants, or supportive medications without explicit instruction from your treating oncologist.

Exclusion Criteria & ER Red Flags

Active infection at needle puncture site – postpone collection until resolved.
Uncontrolled bleeding diathesis, severe thrombocytopenia (<20×10⁹/L) – evaluate risk.
This test requires a physician’s prescription; it is not intended for routine pre-surgery or pregnancy screening. If you are pregnant, consult your doctor before testing.

Seek emergency care if you experience: persistent fever >38.3°C, unprovoked bleeding, sudden neurological changes, or severe bone pain.

Patient FAQ & Clinical Guidance

Q: What does a positive AML1-ETO result mean for my AML treatment?

A positive result confirms RUNX1::RUNX1T1 fusion AML-M2, which is often associated with a favorable prognosis and high response to chemotherapy. تؤكد النتيجة الإيجابية وجود اندماج RUNX1::RUNX1T1 المصنف لسرطان الدم النقوي الحاد M2، وترتبط عادةً بتشخيص أفضل واستجابة ممتازة للعلاج الكيميائي المكثف.

Q: How is the sample collected, and is a home visit available?

A physician or specialist phlebotomist collects bone marrow or peripheral blood under sterile conditions; our VIP mobile service brings ISO-certified cold-chain home collection across the UAE. يجمع طبيب أو أخصائي سحب دم نخاع العظم أو الدم المحيطي بتعقيم كامل؛ خدمتنا المتنقلة توفر جمعاً منزلياً بسلسلة تبريد ISO في كل الإمارات.

Q: Do I need a doctor’s prescription for this?

Yes, a valid prescription from a DHA-licensed oncologist or haematologist is mandatory, except for established monitoring protocols where the laboratory follows physician standing orders. نعم، وصفة طبية سارية من طبيب أورام أو أمراض دم مرخص من DHA إلزامية، باستثناء بروتوكولات المتابعة المعتمدة حيث يتبع المختبر تعليمات الطبيب المسجلة.

دعم ثنائي اللغة متاح